Dalton Transactions is publishing a themed issue dedicated to the inorganic contribution to radiopharmaceutical chemistry entitled “Radiopharmaceuticals for Imaging and Therapy”. This issue is to be Guest Editored by Professor Stephen Faulkner (Oxford University) and Professor Nick Long (Imperial College London).
Radiopharmaceuticals have already made an enormous contribution to the diagnosis and therapy of disease. Rapid development of the field continues, with important new approaches to targeting, bioconjugation and control of biological kinetics as well as through the application and purification of new radioisotopes, the development of new experimental techniques and the application of radioisotopes in multimodal imaging.
The time seems right to highlight and review these developments, and to present them in a single issue to the wider community of inorganic chemists. With this themed issue on radiopharmaceutical chemistry, we are aiming to highlight contributions from leading experts of the field, illustrating the scope of these new developments and analysing their potential in detail.
Submission Deadline: 15 October 2010
Submissions, either communications or full papers, should be high-quality manuscripts of original, unpublished research. To submit a manuscript for this themed issue please use our online submission service.
For further information about this issue please contact us at Dalton@rsc.org.
DNA cleavage by the Cu(II) complex of the DNA-intercalating 9-bis(pyridin-2-ylmethyl)aminobenzo[b]quinolizinium 
